| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 200.97B | 164.50B | 134.90B | 116.61B | 117.93B |
| Gross Profit | 164.79B | 134.34B | 108.94B | 91.36B | 95.28B |
| EBITDA | 104.55B | 86.88B | 59.05B | 37.69B | 55.27B |
| Net Income | 60.46B | 62.36B | 39.10B | 23.20B | 39.37B |
Balance Sheet | |||||
| Total Assets | 366.02B | 276.05B | 229.62B | 185.73B | 165.99B |
| Cash, Cash Equivalents and Short-Term Investments | 81.59B | 77.81B | 65.40B | 40.74B | 48.00B |
| Total Debt | 83.90B | 49.06B | 37.23B | 26.59B | 13.87B |
| Total Liabilities | 148.78B | 93.42B | 76.45B | 60.01B | 41.11B |
| Stockholders Equity | 217.24B | 182.64B | 153.17B | 125.71B | 124.88B |
Cash Flow | |||||
| Free Cash Flow | 46.11B | 54.07B | 43.85B | 19.04B | 39.12B |
| Operating Cash Flow | 115.80B | 91.33B | 71.11B | 50.48B | 57.68B |
| Investing Cash Flow | -102.00B | -47.15B | -24.50B | -28.97B | -7.57B |
| Financing Cash Flow | -20.37B | -40.78B | -19.50B | -22.14B | -50.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $1.45T | 27.52 | 30.56% | 0.32% | 22.17% | -2.66% | |
72 Outperform | $26.96B | 80.88 | 20.89% | ― | 69.71% | ― | |
71 Outperform | $3.69T | 28.69 | 35.00% | 0.26% | 15.22% | 34.19% | |
69 Neutral | $2.29T | 31.67 | 21.87% | ― | 11.48% | 50.70% | |
68 Neutral | $11.66B | 41.90 | 8.74% | ― | 16.79% | 819.94% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
53 Neutral | $8.11B | -29.98 | -20.72% | ― | 11.75% | 49.19% |